Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Daniel Bergemalm"'
Autor:
Isabella Visuri, Carl Eriksson, Sara Karlqvist, Byron Lykiardopoulos, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Real-world data on long-term outcomes of vedolizumab (VDZ) are scarce. Objective: To assess long-term outcomes (up to 3 years) of VDZ in treating inflammatory bowel disease (IBD). Design: A nationwide, prospective multicentre extension of
Externí odkaz:
https://doaj.org/article/520ccc3a7100409a8d39655c69ab7181
Autor:
Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, Ruzan Udumyan, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Jenny Gunnarsson, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, David Öberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel disease (IBD). Methods: This study was a prospective, obser
Externí odkaz:
https://doaj.org/article/546171ef141e431a8b1359defa38ac04
Autor:
Daniel Bergemalm, Sofia Ramström, Caroline Kardeby, Kjell Hultenby, Anna Göthlin Eremo, Carina Sihlbom, Jörgen Bergström, Jan Palmblad, Maria Åström
Publikováno v:
Haematologica, Vol 106, Iss 11 (2020)
In X-linked thrombocytopenia with thalassemia (XLTT; OMIM 314050), caused by the mutation p.R216Q in exon 4 of the GATA1 gene, male hemizygous patients display macrothrombocytopenia, bleeding diathesis and a b-thalassemia trait. Herein, we describe f
Externí odkaz:
https://doaj.org/article/de181fe30dd24397bb5476fb4f1b2fad
Autor:
Daniel Bergemalm, Robert Kruse, Maria Sapnara, Jonas Halfvarson, Elisabeth Hultgren Hörnquist
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174275 (2017)
BACKGROUND:The identification of novel fecal biomarkers in inflammatory bowel disease (IBD) is hampered by the complexity of the human fecal proteome. On the other hand, in experimental mouse models there is probably less variation. We investigated t
Externí odkaz:
https://doaj.org/article/3f7c8e45b3a44e7a9e4a5aaffbb3b811
Autor:
Erik Andersson, Daniel Bergemalm, Robert Kruse, Gunter Neumann, Mauro D'Amato, Dirk Repsilber, Jonas Halfvarson
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186142 (2017)
Genetic and immunological data indicate that inflammatory bowel disease (IBD) are characterized by specific inflammatory protein profiles. However, the serum proteome of IBD is still to be defined. We aimed to characterize the inflammatory serum prot
Externí odkaz:
https://doaj.org/article/ef6b652905774000a7387aba45a77368
Autor:
Karin Forsberg, P Andreas Jonsson, Peter M Andersen, Daniel Bergemalm, Karin S Graffmo, Magnus Hultdin, Johan Jacobsson, Roland Rosquist, Stefan L Marklund, Thomas Brännström
Publikováno v:
PLoS ONE, Vol 5, Iss 7, p e11552 (2010)
Mutations in CuZn-superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS) and are found in 6% of ALS patients. Non-native and aggregation-prone forms of mutant SOD1s are thought to trigger the disease. Two sets of novel antibodies, rais
Externí odkaz:
https://doaj.org/article/4b3d5c889cbf4a1a8f2803fa1292f1dd
Autor:
Konstantinos H. Katsanos, Konstantinos Karmiris, Nanne K. H. de Boer, Frank Phillips, Pierre Ellul, Bram Verstockt, Malgorzata Sladek, Tamás Molnár, Ecco Confer Investigators, Ahmad Albshesh, Daniel Bergemalm, Carl Erikson
Publikováno v:
Journal of Crohn's & colitis, 16(3), 430-435. Elsevier
Phillips, F, Verstockt, B, Sladek, M, de Boer, N, Katsanos, K, Karmiris, K, Albshesh, A, Erikson, C, Bergemalm, D, Molnar, T & Ellul, P 2022, ' Orofacial Granulomatosis Associated with Crohn's Disease : a Multicentre Case Series ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 430-435 . https://doi.org/10.1093/ecco-jcc/jjab158
Phillips, F, Verstockt, B, Sladek, M, de Boer, N, Katsanos, K, Karmiris, K, Albshesh, A, Erikson, C, Bergemalm, D, Molnar, T & Ellul, P 2022, ' Orofacial Granulomatosis Associated with Crohn's Disease : a Multicentre Case Series ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 430-435 . https://doi.org/10.1093/ecco-jcc/jjab158
BackgroundOrofacial granulomatosis [OFG] is a rare syndrome that may be associated with Crohn’s disease [CD]. We aimed to characterise this relationship and the management options in the biologic era.MethodsThis multicentre case series was supporte
Autor:
Mauro D'Amato, Petr Ricanek, Alex Adams, Jonas Christoffer Lindstrøm, Nicholas A. Kennedy, Morten H. Vatn, Fernando Gomollón, Nicholas T. Ventham, Jonas Halfvarson, Christine Olbjørn, Rahul Kalla, Johan D. Söderholm, Daniel Bergemalm, Simen Vatn, Rebecca C Richmond, Jan Krzysztof Nowak, Caroline L Relton, Jørgen Jahnsen, Jack Satsangi, Marieke Pierik
Publikováno v:
Journal of Crohn's & Colitis, 17(2), 170-184. Oxford University Press
Background Epigenetic alterations may provide valuable insights into gene–environment interactions in the pathogenesis of inflammatory bowel disease [IBD]. Methods Genome-wide methylation was measured from peripheral blood using the Illumina 450k p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079c3041e49e3aea6df6864b62c84c43
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-190960
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-190960
Autor:
Hussein Mahajna, Bram Verstockt, Daniel Bergemalm, Fabiana Castiglione, Fransisco Rodríguez-Moranta, Edoardo Savarino, Frank Hoentjen, Talat Bessissow, Jagoda Pokryszka, Anneline Cremer, Piotr Eder, Marie Truyens, Anat Yerushalmy-Feler, María José García, Uri Kopylov
Publikováno v:
Journal of Crohn's and Colitis, 17, 722-727
Journal of Crohn's and Colitis, 17, 5, pp. 722-727
Journal of Crohn's and Colitis, 17, 5, pp. 722-727
Background Idiopathic thrombocytopaenic purpura [ITP] is an acquired haematological disorder with an incidence of 1–6 per 100 00/year. ITP and inflammatory bowel disease [IBD] comorbidity has been reported in the literature, but insights regarding
Autor:
Joel, Thunberg, Olle, Björkqvist, Charlotte R H, Hedin, Anders, Forss, Charlotte, Söderman, Daniel, Bergemalm, Ola, Olén, Henrik, Hjortswang, Hans, Strid, Jonas F, Ludvigsson, Carl, Eriksson, Jonas, Halfvarson
Publikováno v:
United European gastroenterology journal. 10(7)
Background Real-world data on clinical outcomes of ustekinumab in ulcerative colitis are lacking. Objective To assess short- and long-term clinical outcomes of ustekinumab in ulcerative colitis. Methods Adult ulcerative colitis patients without previ